title: [Which node area should be irradiated after neoadjuvant chemotherapy in breast cancer?].
abstract: In addition to achieve breast conserving surgery after neoadjuvant chemotherapy, its indications are growing, especially in Her2 overexpressing and triple negative breast cancers owing to the emergence of new targeted therapies. Radiotherapy belongs to breast cancer management. However, some questions are still unresolved regarding nodes area irradiation after neoadjuvant chemotherapy. This short communication reviews indications of radiotherapy of node areas in breast cancer after neoadjuvant chemotherapy.
authors.affiliation: Département de radiothérapie oncologique, institut du cancer de Montpellier, 208, avenue des Apothicaires, parc Euromédecine, 34298 Montpellier cedex 5, France.
authors.forename: C
authors.initials: C
authors.lastname: Lemanski
authors.affiliation: Département de radiothérapie oncologique, institut du cancer de Montpellier, 208, avenue des Apothicaires, parc Euromédecine, 34298 Montpellier cedex 5, France.
authors.forename: X
authors.initials: X
authors.lastname: Druet
authors.affiliation: Département de radiothérapie oncologique, institut du cancer de Montpellier, 208, avenue des Apothicaires, parc Euromédecine, 34298 Montpellier cedex 5, France; Université de Montpellier, 163, rue Auguste-Broussonnet, 34090 Montpellier, France.
authors.forename: O
authors.initials: O
authors.lastname: Riou
authors.affiliation: Département de radiothérapie oncologique, institut du cancer de Montpellier, 208, avenue des Apothicaires, parc Euromédecine, 34298 Montpellier cedex 5, France.
authors.forename: A
authors.initials: A
authors.lastname: Ducteil
authors.affiliation: Département de radiothérapie oncologique, institut du cancer de Montpellier, 208, avenue des Apothicaires, parc Euromédecine, 34298 Montpellier cedex 5, France; Université de Montpellier, 163, rue Auguste-Broussonnet, 34090 Montpellier, France.
authors.forename: D
authors.initials: D
authors.lastname: Azria
authors.affiliation: Département de radiothérapie oncologique, institut du cancer de Montpellier, 208, avenue des Apothicaires, parc Euromédecine, 34298 Montpellier cedex 5, France; Université de Montpellier, 163, rue Auguste-Broussonnet, 34090 Montpellier, France. Electronic address: Celine.Bourgier@icm.unicancer.fr.
authors.forename: C
authors.initials: C
authors.lastname: Bourgier
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy / Q000517:prevention & control / Q000532:radiotherapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D015182:Lymphatic Irradiation / Q000379:methods*; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control
keywords: Breast cancer; Cancer du sein; Chimiothérapie néoadjuvante; Neoadjuvant chemotherapy; Radiotherapy; Radiothérapie